Reporter March 2024

Roger Dmochowski promoted to Vice President and Executive Medical Director of Perioperative Services

Roger Dmochowski, MD, MMHC, professor of Urology, Surgery, and Obstetrics & Gynecology and director of the Section of Female Pelvic Medicine, has been promoted to Vice President and Executive Medical Director of Perioperative Services at Vanderbilt University Hospital. He will function full time in this role.

New Vanderbilt University Hospital Labor and Delivery entrance helps patients bypass Emergency Department

Pregnant patients who are more than 20 weeks along with a pregnancy-related health issue have a dedicated drop-off location. The VUH Labor and Delivery Entrance, located off 21st Avenue at the new Vivian Thomas Way stoplight, offers quick access to OB triage at Medical Center East’s second-floor entrance in the north tower.

Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women

The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. 

School of Medicine in top 10 in NIH funding: survey

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years.

VUMC joins new consortium of health care leaders in formation of Trustworthy & Responsible AI Network (TRAIN)

At the HIMSS 2024 Global Health Conference, Vanderbilt University Medical Center (VUMC) and other leading academic medical centers joined as Microsoft announced the formation of a new consortium, the Trustworthy & Responsible AI Network (TRAIN).

Scalp cooling allows woman to keep hair during chemotherapy

The Food and Drug Administration first granted marketing approval for the DigniCap system for patients with breast cancer in 2015, then in 2017 the FDA expanded the authorization, making it the first cooling cap cleared for use in cancer patients with solid tumors, such as breast cancer, ovarian cancer and colorectal cancer.

1 2 3